BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1378620)

  • 1. Synthesis of mannosylglucosaminylinositol phospholipids in normal but not paroxysmal nocturnal hemoglobinuria cells.
    Hirose S; Ravi L; Prince GM; Rosenfeld MG; Silber R; Andresen SW; Hazra SV; Medof ME
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6025-9. PubMed ID: 1378620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembly and deacetylation of N-acetylglucosaminyl-plasmanylinositol in normal and affected paroxysmal nocturnal hemoglobinuria cells.
    Hirose S; Ravi L; Hazra SV; Medof ME
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3762-6. PubMed ID: 1708886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective glycosylphosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria granulocytes.
    Mahoney JF; Urakaze M; Hall S; DeGasperi R; Chang HM; Sugiyama E; Warren CD; Borowitz M; Nicholson-Weller A; Rosse WF
    Blood; 1992 Mar; 79(6):1400-3. PubMed ID: 1372185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1- murine lymphoma mutants.
    Armstrong C; Schubert J; Ueda E; Knez JJ; Gelperin D; Hirose S; Silber R; Hollan S; Schmidt RE; Medof ME
    J Biol Chem; 1992 Dec; 267(35):25347-51. PubMed ID: 1460030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of glycoinositol phospholipid anchor assembly in human lymphocytes. Absent mannolipid synthesis in affected T and natural killer cell lines from paroxysmal nocturnal hemoglobinuria patients.
    Schubert J; Schmidt RE; Medof ME
    J Biol Chem; 1993 Mar; 268(9):6281-7. PubMed ID: 8454600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivation and characterization of glycoinositol-phospholipid anchor-defective human K562 cell clones.
    Hirose S; Mohney RP; Mutka SC; Ravi L; Singleton DR; Perry G; Tartakoff AM; Medof ME
    J Biol Chem; 1992 Mar; 267(8):5272-8. PubMed ID: 1371997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of putative glycoinositol phospholipid anchor precursors in mammalian cells. Localization of phosphoethanolamine.
    Hirose S; Prince GM; Sevlever D; Ravi L; Rosenberry TL; Ueda E; Medof ME
    J Biol Chem; 1992 Aug; 267(24):16968-74. PubMed ID: 1380957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian glycosylphosphatidylinositol-anchored proteins and intracellular precursors.
    Hirose S; Knez JJ; Medof ME
    Methods Enzymol; 1995; 250():582-614. PubMed ID: 7651180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
    Edberg JC; Salmon JE; Whitlow M; Kimberly RP
    J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired glycosylation of glycosylphosphatidylinositol-anchor synthesis in paroxysmal nocturnal hemoglobinuria leucocytes.
    Hidaka M; Nagakura S; Horikawa K; Kawaguchi T; Iwamoto N; Kagimoto T; Takatsuki K; Nakakuma H
    Biochem Biophys Res Commun; 1993 Mar; 191(2):571-9. PubMed ID: 8461014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosyl-phosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria: partial or complete defect in an early step.
    Norris J; Hall S; Ware RE; Kamitani T; Chang HM; Yeh E; Rosse WF
    Blood; 1994 Feb; 83(3):816-21. PubMed ID: 7507735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoinositol phospholipid anchor-defective K562 mutants with biochemical lesions distinct from those in Thy-1- murine lymphoma mutants.
    Mohney RP; Knez JJ; Ravi L; Sevlever D; Rosenberry TL; Hirose S; Medof ME
    J Biol Chem; 1994 Mar; 269(9):6536-42. PubMed ID: 7907094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Bessler M; Mason PJ; Watkins WM; Luzzatto L
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5272-6. PubMed ID: 8389477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A candidate mammalian glycoinositol phospholipid precursor containing three phosphoethanolamines.
    Ueda E; Sevlever D; Prince GM; Rosenberry TL; Hirose S; Medof ME
    J Biol Chem; 1993 May; 268(14):9998-10002. PubMed ID: 7683688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of exogenous sn-1-alkyl-sn-2-lyso-glucosaminyl-phosphatidylinositol in HeLa D cells: accumulation of glucosaminyl(acyl)phosphatidylinositol in a metabolically inert compartment.
    Wongkajornsilp A; Sevlever D; Rosenberry TL
    Biochem J; 2001 Oct; 359(Pt 2):305-13. PubMed ID: 11583576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxysmal nocturnal hemoglobinuria and glycosyl phosphatidylinositol anchored proteins that regulate complement.
    Parker CJ
    Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):36-42. PubMed ID: 1718642
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of recombinant transmembrane CD59 in paroxysmal nocturnal hemoglobinuria B cells confers resistance to human complement.
    Rother RP; Rollins SA; Mennone J; Chodera A; Fidel SA; Bessler M; Hillmen P; Squinto SP
    Blood; 1994 Oct; 84(8):2604-11. PubMed ID: 7522635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59.
    Ratnoff WD; Knez JJ; Prince GM; Okada H; Lachmann PJ; Medof ME
    Clin Exp Immunol; 1992 Mar; 87(3):415-21. PubMed ID: 1371955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines established from patients with paroxysmal nocturnal hemoglobinuria.
    Ueda E; Nishimura J; Kitani T; Nasu K; Kageyama T; Kim YU; Takeda J; Kinoshita T
    Int Immunol; 1992 Nov; 4(11):1263-71. PubMed ID: 1282030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
    Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.